AFC-TAB-023

antibody from Creative Biolabs
Targeting: IL2RA CD25, IDDM10, IL2R
Provider product page for AFC-TAB-023
No application information provided.

Antibody data

Product number
AFC-TAB-023 - Provider product page
Provider
Creative Biolabs
Product name
Afuco? Anti-IL2RA ADCC Recombinant Antibody (Daclizumab), ADCC Enhanced
Antibody type
Monoclonal
Description
This product is an ADCC enhanced antibody produced by our Afuco? platform. Recombinant monoclonal antibody to Human CD25. Daclizumab (trade name daclizumab) is a therapeutic humanized monoclonal antibody. It is used to prevent rejection in organ transplantation, especially in kidney transplants. The drug is also under investigation for the treatment of multiple sclerosis. Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T cells.
Reactivity
Human
Conjugate
Unconjugated
Antibody clone number
Daclizumab
Storage
Store at +4¡ãC short term (1-2 weeks). Aliquot and store at -20¡ãC long term. Avoid repeated freeze/thaw cycles.
IL2RA protein structure - AFC-TAB-023 shown in red.